Skip to main content

A prospective registry study of a primary melanoma gene-signature to predict sentinel node (SN) status and determine its prognostic value for more accurate staging of SN-negative melanoma patients

Clinical Trial Grant
Duke Scholars

Administered By

Surgical Oncology

Awarded By

SkylineDx

Start Date

July 29, 2022

End Date

March 31, 2027
 

Administered By

Surgical Oncology

Awarded By

SkylineDx

Start Date

July 29, 2022

End Date

March 31, 2027